Zymeworks (NasdaqGS:ZYME) Q4 2025 Earnings call March 02, 2026 08:30 AM ET Company ParticipantsBijal Desai - Senior Vice President, FinanceJon Miller - Managing DirectorKenneth Galbraith - Chair, CEO and Interim CFOMayank Mamtani - Senior Managing Director and Group Head of HealthcarePaul Moore - Chief Scientific OfficerReni Benjamin - Managing DirectorSabeen Mekan - SVP and Chief Medical OfficerScott Platshon - Acting Chief Investment OfficerShrinal Inamdar - VP of Investor RelationsStephen Willey - Managi ...

Zymeworks (NasdaqGS:ZYME) Q4 2025 Earnings call March 02, 2026 08:30 AM ET Speaker8Welcome to the Zymeworks fourth quarter 2025 results conference call and webcast. As a reminder, all participants are in listen-only mode, and the conference is being recorded. After the presentation, there will be an opportunity to ask questions. I would now like to turn the conference over to Shrinal Inamdar, Vice President of Investor Relations. Shrinal, please go ahead.Speaker13Thank you, operator, and good morning, every ...